Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

T cells in systemic sclerosis: a reappraisal

Open access
O'Reilly, S., Hugle, T., van Laar, J. M. · 2012 · Rheumatology

Abstract

SSc is an autoimmune disease characterized by inflammation and extracellular matrix deposition that ultimately leads to loss of organ function. T cells appear to play a prominent role in its pathogenesis. The evidence for this comes from their being at the site of fibrosis, their activated phenotype and alteration in their number and frequency in peripheral blood. This review examines the role of T cells in the pathogenesis of SSc and specifically examines the key soluble profibrotic mediators (IL-4, IL-6, IL-13) secreted by Th2 cells and their interactions with fibroblasts that deposit excess extracellular matrix leading to fibrosis. We finally examine possible therapeutic options in targeting T-cell mediators to disrupt the cellular interactions between T cells and fibroblasts that serve to drive the fibrotic response. One of the factors driving fibrosis is IL-6 and this can be neutralized in vivo not only to limit IL-6-driven tissue fibrosis but concomitantly to suppress switching of Tregs to Th17 T cells that will provide more IL-6, thus perpetuating the fibrosis. Taken together, these data implicate the role of T cells in SSc and suggest that Th2-polarized T cells and the fibrotic mediators subsequently released directly induce fibrosis. Targeting such cytokines may be therapeutic not only in SSc but more generally in diseases where fibrosis is directed by inflammatory signals.

Overview

Integrity signals

Registry

Crossref · 10.1093/rheumatology/kes090

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 87 references

Research works printed but not linked: 4

  1. Isaacs, 1996, The Journal of Rheumatology, 23, 1103
  2. 1996, 4, 573
  3. 2010, Annals of the Rheumatic Diseases, 70, 1475
  4. Atamas, 1999, Arthritis and rheumatism, 42, 1168, 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L · doi:10.1002/1529-0131(199906)42:6<1168::aid-anr13>3.0.co;2-l

Cited by

See all 218

Metadata

Authors
O'Reilly, S., Hugle, T., & van Laar, J. M.
Venue
Rheumatology
Published
2012-05-09
Volume
51
Issue
9
Pages
1540-1549
ISSN
  • 1462-0324 (ISSN-L)
  • 1462-0332
OpenAlex
W2146945647
Cited by
218
References
87
Citations by year
2026: 2 · 2025: 8 · 2024: 21 · 2023: 15 · 2022: 22 · 2021: 14 · 2020: 14 · 2019: 25 · 2018: 17 · 2017: 17 · 2016: 9 · 2015: 22 · 2014: 16 · 2013: 14 · 2012: 2
FWCI
2.53
Type
journal article
Language
en
Open access
Locations
  • Lara D. Veeken (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Keywords
systemic sclerosis, T cells, fibrosis, Th2 cells, interleukin-6, IL-4, IL-13, extracellular matrix deposition, autoimmune disease pathogenesis, IL-6 inhibition, cytokine-targeted therapy
MeSH terms
Cell Differentiation, Fibroblasts, Fibrosis, Humans, Interleukins, Scleroderma, Systemic, Transcription Factors, Biomarkers, Autoimmunity, Cytokines, Th2 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: T cells in systemic sclerosis: a reappraisal. https://app.cochat.ai/papers/10.1093/rheumatology/kes090
The paper
O'Reilly, S., Hugle, T., & van Laar, J. M. (2012). T cells in systemic sclerosis: a reappraisal. Rheumatology. https://doi.org/10.1093/rheumatology/kes090

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.